Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Giess

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Mechanisms of Ageing and Development|October 27, 1995
Localisation and association of pathomorphological changes at the brainstem in Alzheimer's diseaseR Giess, W Schlote
Deutsche Medizinische Wochenschrift (1946)|January 1, 2000
[Unilateral mydriasis after cutting back angel trumpet]R Giess, W Müllges
Deutsche Medizinische Wochenschrift (1946)|August 14, 2001
[Ciguatera: clinical relevance of a marine neurotoxin]K Ruprecht, P Rieckmann, R Giess
Deutsche Medizinische Wochenschrift (1946)|November 24, 1998
[Juvenile cerebral ischaemia caused by designer drugs]R Giess, P Rieckmann, W Müllges
Journal of Pain and Symptom Management|October 12, 1999
Epi-arachnoidal drug deposit: a rare complication of intrathecal drug therapyG Ochs, R Giess, M Bendszus, et al.
Molecular Human Reproduction|May 26, 1999
Leukaemia inhibitory factor gene mutations in infertile womenR Giess, I Tanasescu, T Steck, et al.
Journal of Neuroimmunology|February 23, 2000
Genetic variation at position -1082 of the interleukin 10 (IL10) promotor and the outcome of multiple sclerosisM Mäurer, N Kruse, R Giess, et al.
Muscle & Nerve|February 18, 1998
Potential implications of a ciliary neurotrophic factor gene mutation in a German population of patients with motor neuron diseaseR Giess, R Goetz, B Schrank, et al.
Journal of Neurology|November 7, 1999
Gene polymorphism at position -308 of the tumor necrosis factor alpha promotor is not associated with disease progression in multiple sclerosis patientsM Mäurer, N Kruse, R Giess, et al.
Der Nervenarzt|January 19, 2000
[Clenbuterol in amyotrophic lateral sclerosis. No indication for a positive effect]I Puls, M Beck, R Giess, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Mechanisms of Ageing and Development|October 27, 1995
Localisation and association of pathomorphological changes at the brainstem in Alzheimer's diseaseR Giess, W Schlote
Deutsche Medizinische Wochenschrift (1946)|January 1, 2000
[Unilateral mydriasis after cutting back angel trumpet]R Giess, W Müllges
Deutsche Medizinische Wochenschrift (1946)|August 14, 2001
[Ciguatera: clinical relevance of a marine neurotoxin]K Ruprecht, P Rieckmann, R Giess
Deutsche Medizinische Wochenschrift (1946)|November 24, 1998
[Juvenile cerebral ischaemia caused by designer drugs]R Giess, P Rieckmann, W Müllges
Journal of Pain and Symptom Management|October 12, 1999
Epi-arachnoidal drug deposit: a rare complication of intrathecal drug therapyG Ochs, R Giess, M Bendszus, et al.
Molecular Human Reproduction|May 26, 1999
Leukaemia inhibitory factor gene mutations in infertile womenR Giess, I Tanasescu, T Steck, et al.
Journal of Neuroimmunology|February 23, 2000
Genetic variation at position -1082 of the interleukin 10 (IL10) promotor and the outcome of multiple sclerosisM Mäurer, N Kruse, R Giess, et al.
Muscle & Nerve|February 18, 1998
Potential implications of a ciliary neurotrophic factor gene mutation in a German population of patients with motor neuron diseaseR Giess, R Goetz, B Schrank, et al.
Journal of Neurology|November 7, 1999
Gene polymorphism at position -308 of the tumor necrosis factor alpha promotor is not associated with disease progression in multiple sclerosis patientsM Mäurer, N Kruse, R Giess, et al.
Der Nervenarzt|January 19, 2000
[Clenbuterol in amyotrophic lateral sclerosis. No indication for a positive effect]I Puls, M Beck, R Giess, et al.
Pageof 2